Page last updated: 2024-12-08

salicylideneaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

salicylideneaniline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID136621
CHEMBL ID205927
SCHEMBL ID12809869
SCHEMBL ID13325913
SCHEMBL ID347861
MeSH IDM0497961

Synonyms (54)

Synonym
nsc 14880
nsc 68443
2-hydroxybenzaldehyde n-phenylimine
.alpha.-(phenylimino)-ortho-cresol
salicylidene aniline
nsc-68443
nsc68443
nsc-14880
779-84-0
phenol, 2-[(phenylimino)methyl]-
nsc14880
salicylideneaniline
o-hydroxy benzylidene aniline
salicylideneaniline, 97%
2-((phenylimino)methyl)phenol
bdbm50185241
STK825387
2-[(e)-(phenylimino)methyl]phenol
gbr-11840
CHEMBL205927 ,
n-salicylalaniline
n-salicylideneaniline
AKOS002662755
AKOS004906517
6-(anilinomethylidene)cyclohexa-2,4-dien-1-one
31519-65-0
phenol, 2-[(e)-(phenylimino)methyl]-
103886-92-6
SCHEMBL12809869
SCHEMBL13325913
SCHEMBL347861
n-(o-hydroxybenzylidene)aniline
QIYHCQVVYSSDTI-UHFFFAOYSA-N
QIYHCQVVYSSDTI-GXDHUFHOSA-N
phenol, 2-((phenylimino)methyl)-
n-(2-hydroxybenzylidene)aniline
o-cresol, .alpha.-phenyl imino-
2-[(phenylimino)methyl]phenol #
mfcd00020066
2-hydroxybenzylideneaniline
salicylalaniline
beta-2-salicylideneaniline
VS-13411
2-[(phenylimino)methyl]phenol
(e)-2-((phenylimino)methyl)phenol
acetic-d3acid-d
DTXSID001203180
(6e)-6-[(phenylamino)methylene]-2,4-cyclohexadien-1-one
BBL036310
2-(phenyliminomethyl)phenol
D92243
DTXSID50870775
CS-0085921
SY049501
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)250.00000.03403.987110.0000AID1611936
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)1,000.00000.00002.015110.0000AID262947
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (16)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID474870Growth inhibition of human HepG2 cells after 72 hrs by sulforhodamine B assay2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Antioxidant and antiproliferative activities of hydroxyl-substituted Schiff bases.
AID474869Antioxidant activity assessed as galvinoxyl radical scavenging activity in methanol by UV-visible spectroscopy2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Antioxidant and antiproliferative activities of hydroxyl-substituted Schiff bases.
AID1060591Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric analysis2014European journal of medicinal chemistry, Jan, Volume: 71Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
AID1611936Inhibition of Agaricus bisporus tyrosinase using L-tyrosine as substrate after 60 mins by spectrophotometric analysis2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Inhibitors of Melanogenesis: An Updated Review.
AID674915Antioxidant activity assessed as DPPH scavenging activity after 30 mins by microplate reader method2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
The antioxidant effect of imine resveratrol analogues.
AID262947Inhibition of human CYP2D6 expressed in Escherichia coli JM1092006Journal of medicinal chemistry, Apr-20, Volume: 49, Issue:8
Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking.
AID1060589Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM after 46 to 48 hrs by thioflavin-T based fluorometric assay2014European journal of medicinal chemistry, Jan, Volume: 71Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
AID474868Antioxidant activity assessed as galvinoxyl radical scavenging activity in ethyl acetate by UV-visible spectroscopy2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Antioxidant and antiproliferative activities of hydroxyl-substituted Schiff bases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (30.43)29.6817
2010's14 (60.87)24.3611
2020's2 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.01 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index35.52 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (95.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]